Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€10.85
23.04.24
€15.00
23.04.25
2.75%
01:00

buy
Arcadium Lithium Plc

Start price
Target price
Perf. (%)
€3.68
23.04.24
€5.00
23.04.25
-0.54%
01:00

buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.49
23.04.24
€3.00
23.04.25
-9.36%
01:00

Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
buy
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€4.29
15.04.24
-
15.04.25
3.80%
01:00

buy
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€7.07
15.04.24
-
15.04.25
-6.99%
01:00

buy
Coeur Mining Inc.

Start price
Target price
Perf. (%)
€4.15
15.04.24
-
15.04.25
11.03%
01:00

buy
Hecla Mining Corp.

Start price
Target price
Perf. (%)
€5.07
15.04.24
-
15.04.25
-5.86%
01:00

buy
Endeavour Silver Corp.

Start price
Target price
Perf. (%)
€2.54
15.04.24
-
15.04.25
2.21%
01:00

Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.68
23.04.24
-
23.04.25
-16.85%
01:00

Agba Group Holding Ltd.

Start price
Target price
Perf. (%)
€2.30
23.04.24
-
23.04.25
-21.30%
01:00

buy
Avalo Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.70
19.04.24
-
19.04.25
26.17%
01:00

Very good company culture
Could be worthwhile Investment >10% per year
Few uniques
buy
China Sxt Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.10
16.04.24
-
16.04.25
-53.71%
01:00

buy
Marinus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.50
15.04.24
-
15.04.25
-12.67%
01:00

Delticom AG

Start price
Target price
Perf. (%)
€2.06
15.04.24
-
15.04.25
21.36%
01:00

High valuation
Probably not worthwhile Investment
Low dividend yield expected
negative Cash Flow expected
Fair Value Reit-Ag

Start price
Target price
Perf. (%)
€3.66
15.04.24
-
15.04.25
2.73%
01:00

Medium risks for its business
negative Cash Flow expected
EBIT decline/stagnation expected
Increased challenges to pay loans and raise capital
buy
Alba SE

Start price
Target price
Perf. (%)
€10.50
15.04.24
€15.00
15.04.25
0.00%
01:00

Revenue growth >5% per year expected
Future proof or reliable business model
EBIT growth >5% per year expected
Top 10 in its market
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.54
15.04.24
-
15.04.25
-13.62%
01:00

Could be worthwhile Investment >10% per year
Normal challenges to pay loans and raise capital
EBIT growth >5% per year expected
High dividend yield expected
buy
Coupang Inc.

Start price
Target price
Perf. (%)
€20.35
15.04.24
€33.00
15.04.25
5.21%
01:00

positive Cash Flow expected
Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
buy
Globe Life Inc.

Start price
Target price
Perf. (%)
€55.50
14.04.24
-
14.04.25
27.93%
01:00

Could be worthwhile Investment >10% per year
buy
Informatica Inc.

Start price
Target price
Perf. (%)
€38.80
14.04.24
-
14.04.25
-23.20%
01:00

Could be worthwhile Investment >10% per year
buy
Q32 Bio Inc.

Start price
Target price
Perf. (%)
€14.94
13.04.24
-
13.04.25
-
01:00

Could be worthwhile Investment >10% per year
buy
Entera Bio

Start price
Target price
Perf. (%)
€2.32
13.04.24
-
13.04.25
-19.83%
01:00

Could be worthwhile Investment >10% per year
Liquidia Technologies Inc

Start price
Target price
Perf. (%)
€13.78
13.04.24
€12.00
13.04.25
-15.09%
01:00

Probably not worthwhile Investment
EBIT decline/stagnation expected
Low dividend yield expected
Revenue decline/stagnation expected
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-6.54%
01:00

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-31.27%
01:00

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth